Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The adenosine A1 receptor (A1AR) is a G protein-coupled receptor that uses adenosine as its endogenous ligand. It is widely distributed throughout the body, with high expression in the central nervous system and moderate expression in peripheral tissues such as the heart, kidney, and pancreas. A1AR activation inhibits neurotransmitter release, reduces heart rate and contractility, and reduces renal blood flow. It is a potential therapeutic target for cardiac arrhythmias, neuroprotection, and sleep disorders.
Gi/o protein activation, inhibition of adenylate cyclase, decreased cAMP levels, activation of phospholipase C, arachidonic acid production, modulation of ion channels
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Adenosine Receptor A1 Subtype (A1AR).